Eli Lilly launches access initiative. Eli Lilly stock costs EUR 1,016.60
Published on 10/03/2026 at 12:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eli Lilly and Company launched its Change the Course Commitment on September 28, 2026, according to the company’s news release. The initiative aims to achieve parity in the number of patients treated with Lilly’s diabetes and obesity medicines in resource-limited settings and high-income countries before 2040. On October 3, 2026, Eli Lilly stock stood at EUR 1,016.60 in weekend trading at Lang & Schwarz at 12:55 p.m. CEST, or 0.01 percent below the EUR 1,016.70 close at Lang & Schwarz on October 2, 2026.
Weekend trading
Lang & Schwarz quoted Eli Lilly at EUR 1,016.60, with a bid of EUR 1,015.60 and an ask of EUR 1,017.60. The price was EUR 0.10 below the close at Lang & Schwarz on October 2, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Eli Lilly stock.
The last Xetra trading day
The last Xetra trading day’s reference close at Lang & Schwarz was EUR 1,016.70 on October 2, 2026. Xetra remains closed on October 3, 2026.
Lilly’s global access initiative
Under the Change the Course Commitment, Lilly said it will register innovative diabetes and obesity medicines in low- and middle-income countries and work with health systems, regulators, global health organizations and other collaborators. The company also said its Lilly 30x30 global health initiative expanded access to quality healthcare for 40 million people in resource-limited settings in 2025, exceeding its original goal of reaching 30 million people annually by 2030. Lilly said it will report progress through its annual Sustainability Report and at key global health forums, according to the company release.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
